{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:51:08Z","timestamp":1791039068487,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.neulet.2004.07.061","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T21:03:33Z","timestamp":1095195813000},"page":"36-39","source":"Crossref","is-referenced-by-count":73,"title":["Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases"],"prefix":"10.1016","volume":"370","author":[{"given":"Petra","family":"Steinacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Mollenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Bibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Cepek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Esselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brechlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Lewczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Poser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans A.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2004.07.061_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jnnp.64.3.298","article-title":"Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study","volume":"64","author":"Andreasen","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2004.07.061_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch. Neurol."},{"issue":"52","key":"10.1016\/j.neulet.2004.07.061_bib3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/BF01466734","article-title":"Protein size and cerebrospinal fluid composition","volume":"15","author":"Felgenhauer","year":"1974","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.neulet.2004.07.061_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0009-8981(97)00255-6","article-title":"Fatty acid-binding protein and the early detection of acute myocardial infarction","volume":"272","author":"Glatz","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neulet.2004.07.061_bib5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/pmic.200300478","article-title":"A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease","volume":"3","author":"Guillaume","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.neulet.2004.07.061_bib6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1\u201342) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2004.07.061_bib7","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2004.07.061_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2004.07.061_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"38","author":"Motter","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2004.07.061_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","article-title":"Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"225","author":"Otto","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2004.07.061_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.54.5.1099","article-title":"Decreased beta-amyloid1\u201342 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"54","author":"Otto","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2004.07.061_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","article-title":"Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"58","author":"Otto","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2004.07.061_bib13","first-page":"191","article-title":"Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease","volume":"21","author":"Otto","year":"2003","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.neulet.2004.07.061_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2014a concept common to normal blood\u2013CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2004.07.061_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2004.07.061_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1385\/JMN:16:2-3:133","article-title":"Fatty acid-binding proteins of nervous tissue","volume":"16","author":"Veerkamp","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2004.07.061_bib17","unstructured":"WHO: World Health Organisation, Human transmissible spongiform encephalopathy, Wkly. Epidemiol. Rec. 73 (1998) 361\u2013365."},{"key":"10.1016\/j.neulet.2004.07.061_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ana.10661","article-title":"Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"54","author":"Wiltfang","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2004.07.061_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index rating for diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.neulet.2004.07.061_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1074\/mcp.M300066-MCP200","article-title":"Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study","volume":"3","author":"Zimmermann-Ivol","year":"2004","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394004009450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394004009450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T23:21:35Z","timestamp":1549236095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394004009450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0304394004009450"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2004.07.061","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}